Find out about the COVID-19 vaccines, the benefits of COVID-19 vaccination and the possible side effects.

Bhattacharya attacked study's test-negative design, a staple of vaccine effectiveness rese ...

Novavax (NVAX) stock is in focus as Shah Capital again slams the company's leadership despite shareholder backing at the AGM. Read more here.

Add Yahoo as a preferred source to see more of our stories on Google. Heeney has designed a fundamental new vaccine technology that could prevent future pandemics before they begin. (CREDIT: ...

A comprehensive new review published in The Lancet affirms that currently approved mRNA vaccines are safe and highly ...

The COVID-19 vaccine lowered the risk of cardiovascular issues associated with the virus by around 40 percent, according to new research. The study, which was published in JAMA Internal Medicine on ...

A vial of the Phase 3 Novavax coronavirus vaccine is seen ready for use in the trial at St. George's University hospital in London, on Oct. 7, 2020. (Alastair Grant/AP) (CN) — Billions of euros, ...

The coronavirus vaccine reduced the risk of major cardiovascular events linked to covid-19 - strokes, heart attacks, and hospitalization from heart disease - by about 40 percent, according to a new ...

A sweeping global review led by researchers at the University of British Columbia has found that mRNA vaccines—now ...

Share on Pinterest What does the ‘world-first’ vaccine designed by artificial intelligence mean for public health? Image credit: Luis Velasco/Getty Images Researchers at the University of Cambridge ...

Although most Americans have eschewed seasonal COVID-19 vaccines, the updated shots continue to show significant protection against cardiovascular disease, especially for those over age 75 and those ...

Moderna (MRNA) has surged 94% in 2026 so far, crushing Pfizer (PFE) at just +4% and beating Novavax (NVAX) at +41%, as Moderna's leadership restructuring has signaled a 2027-2028 product launch push.